Get the Stockscreener App
389.62
1.94%
7.43
Pre-market:
388.31
-1.31
-0.34%
Overview
News
Price History
Option Chain
Financials
Why HCA Down?
Discussions
Forecast
Dividend History
Hca Healthcare Inc stock is traded at $389.62, with a volume of 1.98M.
It is up +1.94% in the last 24 hours and down -0.53% over the past month.
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.
See More
Previous Close:
$382.19
Open:
$383.63
24h Volume:
1.98M
Relative Volume:
1.22
Market Cap:
$86.43B
Revenue:
$76.39B
Net Income/Loss:
$7.81B
P/E Ratio:
13.40
EPS:
29.0772
Net Cash Flow:
$7.93B
1W Performance:
+5.18%
1M Performance:
-0.53%
6M Performance:
-22.98%
1Y Performance:
+16.54%
1-Day Range:
$383.63
$392.66
1-Week Range:
$366.51
$399.00
52-Week Range:
$331.61
$556.52
Hca Healthcare Inc Stock (HCA) Company Profile
Name
Hca Healthcare Inc
Sector
Industry
Phone
(615) 344-9551
Address
ONE PARK PLZ, NASHVILLE, TN
Compare HCA vs THC, DVA, FMS, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HCA
Hca Healthcare Inc
|
389.62 | 84.78B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
243.36 | 20.09B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
236.31 | 15.11B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
24.87 | 13.21B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
113.88 | 11.20B | 6.07B | 793.80M | 464.40M | 5.9914 |
Hca Healthcare Inc Stock (HCA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-25 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-14-25 | Resumed | Goldman | Buy |
| Jul-28-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-16-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-29-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Apr-15-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Dec-17-24 | Resumed | JP Morgan | Neutral |
| Nov-25-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Nov-22-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-03-24 | Initiated | Morgan Stanley | Equal-Weight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jan-04-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-11-23 | Downgrade | Goldman | Buy → Neutral |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-19-23 | Resumed | JP Morgan | Neutral |
| Jul-06-22 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-29-22 | Initiated | Wells Fargo | Equal Weight |
| Jan-10-22 | Resumed | Citigroup | Buy |
| Dec-21-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-24-21 | Initiated | UBS | Buy |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Jul-09-21 | Initiated | Seaport Global Securities | Buy |
| May-13-21 | Resumed | Citigroup | Neutral |
| Apr-26-21 | Downgrade | Citigroup | Buy → Neutral |
| Dec-15-20 | Initiated | Goldman | Buy |
| Dec-14-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Sep-21-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-13-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-06-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jul-10-19 | Upgrade | Goldman | Neutral → Buy |
| Apr-23-19 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Nov-16-18 | Initiated | UBS | Buy |
| Mar-23-18 | Resumed | Mizuho | Buy |
| Jan-03-18 | Initiated | Goldman | Neutral |
| Jan-03-18 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Dec-20-17 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-12-17 | Upgrade | Citigroup | Neutral → Buy |
| Nov-30-17 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-06-17 | Reiterated | Citigroup | Neutral |
| Nov-01-17 | Reiterated | Mizuho | Buy |
| Jul-26-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-28-17 | Initiated | Argus | Buy |
View All
Hca Healthcare Inc Stock (HCA) Latest News
Tenet Healthcare Tops Q2 Earnings Estimates, Raises 2026 Outlook - TradingView
HCA Maintained by UBS -- Price Target Lowered to $579 - GuruFocus
HCA Healthcare Q2 Results: Revenue rises 8.7% YoY to $20.23 billion - scanx.trade
HCA Maintains Rating by Morgan Stanley -- Price Target Lowered t - GuruFocus
Behind HCA's Q2 Beat: One-Time Medicaid Boost and a Growing Insurance Headwind - Benzinga
Almost all of HCA’s Affordable Care Act patients are going uninsured. Here’s how that affected Q2 - Healthcare Dive
HCA Healthcare Analysts Slash Their Forecasts After Q2 Results - Benzinga
Jordan Fulkerson named CFO of HCA Florida Memorial Hospital - Jacksonville Daily Record
HCA's Health Insurance Exchange Headwinds, Surgical Softness Led to Guidance Reset, RBC Says - marketscreener.com
KeyBanc cuts HCA Healthcare stock price target on weaker HIX dynamics - Investing.com
Truist cuts HCA Healthcare stock price target on weaker guidance - Investing.com
HCA Maintained by Truist Securities -- Price Target Lowered to $495 - GuruFocus
Truist cuts HCA Healthcare stock price target on weaker guidance By Investing.com - Investing.com Canada
UBS Adjusts HCA Healthcare Price Target to $579 From $635, Maintains Buy Rating - marketscreener.com
HCA Healthcare (NYSE:HCA) Earns "Outperform" Rating from Royal Bank Of Canada - MarketBeat
Bernstein Adjusts HCA Healthcare Price Target to $426 From $413, Maintains Market Perform Rating - marketscreener.com
Oppenheimer Has Lowered Expectations for HCA Healthcare (NYSE:HCA) Stock Price - MarketBeat
HCA Healthcare Reports Second Quarter 2026 Results - marketscreener.com
Oppenheimer Cuts Price Target on HCA Healthcare to $485 From $520, Keeps Outperform Rating - Moomoo
HCA Maintained by Keybanc -- Price Target Lowered to $435 - GuruFocus
KeyCorp Has Lowered Expectations for HCA Healthcare (NYSE:HCA) Stock Price - MarketBeat
HCA Healthcare (NYSE:HCA) Price Target Cut to $387.00 by Analysts at Barclays - MarketBeat
Robert W. Baird Cuts HCA Healthcare (NYSE:HCA) Price Target to $393.00 - MarketBeat
Deutsche Bank Cuts HCA Healthcare Price Target to $476 From $540, Maintains Buy Rating - marketscreener.com
Truist Trims Price Target on HCA Healthcare to $495 From $535, Keeps Buy Rating - marketscreener.com
KeyBanc Adjusts Price Target on HCA Healthcare to $435 From $475, Maintains Overweight Rating - marketscreener.com
Barclays Adjusts Price Target on HCA Healthcare to $387 From $402, Maintains Equalweight Rating - marketscreener.com
Lazard Asset Management LLC Boosts Stake in HCA Healthcare, Inc. $HCA - MarketBeat
Lombard Odier Asset Management Switzerland SA Takes Position in HCA Healthcare, Inc. $HCA - MarketBeat
Morgan Stanley Adjusts PT on HCA Healthcare to $380 From $425, Maintains Underweight Rating - Moomoo
HCA Healthcare stock edges higher as strong Q2 2026 results support guidance - Ad-hoc-news.de
2,761 Shares in HCA Healthcare, Inc. $HCA Purchased by Caxton Associates LLP - MarketBeat
Bank of Nova Scotia Buys 12,749 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare (HCA) Stock Faces Bullish Narrative Test As Net Margin Reaches 8.8% - Sahm
HCA Healthcare (HCA) Faces Third Straight Year Of Mission Health Compliance Concerns - Yahoo Finance
HCA Healthcare Reported Q2 Earnings. Here’s What the Guide Cut Really Means. - TIKR.com
Healthcare of Ontario Pension Plan Trust Fund Has $180.51 Million Stock Holdings in HCA Healthcare, Inc. $HCA - MarketBeat
Lido Advisors LLC Has $5.62 Million Stock Holdings in HCA Healthcare, Inc. $HCA - MarketBeat
Cumberland Partners Ltd Lowers Stake in HCA Healthcare, Inc. $HCA - MarketBeat
Epoch Investment Partners Inc. Cuts Stock Position in HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare stock edges higher as strong Q1 2026 earnings and guidance underpin valuation - AD HOC NEWS
HCA Healthcare, Inc. Revenue Breakdown – NYSE:HCA - TradingView
HCA Healthcare (HCA) Reports Q2 2026 Earnings Amid Payer Mix Cha - GuruFocus
'Potential non-compliance' noted in 2025 Mission purchase agreement - WLOS
HCA Healthcare (HCA) Reports Q2 Earnings, Revises 2026 Guidance - GuruFocus
HCA Q2 FY2026 earnings call - finance.biggo.com
HCA Healthcare Inc (HCA) Q2 2026 Earnings Call Highlights: Navigating Growth Amidst Challenges - Yahoo! Finance Canada
HCA Healthcare Inc Revenue Breakdown – MUN:2BH - TradingView
HCA Healthcare, Inc. (HCA) Stock Forecasts - Yahoo Finance
HCA Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages HCA Healthcare, Inc. (NYSE: HCA) Investors to Contact the Firm - NewMediaWire
HCA: EPS up 11% in Q2, but exchange attrition drove uninsured volumes and pressured EBITDA - TradingView
Hca Healthcare Inc Stock (HCA) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):